Monitor regulatory approvals and closing conditions through Q1 2027. The partnership with Wittington (Weston family) brings strong retail/pharmacy operating expertise; any delays or financing changes would be key watchpoints.
Price Chart
Executive Summary
Fairfax Financial Holdings announced a partnership with Wittington Investments to acquire Boots (UK/Ireland retail, opticians, No7 Beauty, and Thailand/franchised operations) for approximately US$8.9 billion including assumed debt. Fairfax will provide up to US$2.3 billion in equity and own 50% of Boots, with Wittington holding operational control. The transaction is expected to close in Q1 2027.
Key Facts
- Total purchase price for Boots: approximately US$8.9 billion (inclusive of assumed debt)
- Fairfax equity commitment: up to approximately US$2.3 billion
- Fairfax will own 50% of Boots equity post-closing
- Wittington Investments (Weston family) will have operational control; Galen Weston to serve as Chair
- Transaction expected to close in Q1 2027
- Excluded from deal: Boots Group's interests in Farmacias Benavides and Alliance Healthcare Deutschland
Financial Impact
Fairfax committing up to ~US$2.3B equity for a 50% stake in a ~US$8.9B enterprise value acquisition of Boots, a leading UK pharmacy/beauty retailer.
Risk Factors
- Transaction failure or delay due to regulatory or customary closing conditions
- Integration and operational performance of Boots under new ownership
- Fairfax's capital allocation concentration in a single retail asset
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-114243 |
| Document: tm2627176d1_6k.htm | 0001104659-26-114243 |
| Document: 0001104659-26-114243-index-headers.html | 0001104659-26-114243 |
| Document: 0001104659-26-114243-index.html | 0001104659-26-114243 |
| Document: 0001104659-26-114243.txt | 0001104659-26-114243 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $1,750.00 | awaiting T+5 | — | $1,754.00 (+0.23%) |
Oct 14, 2026 13d ago | 6-K | $1,699.00 $1,792.47 | ▲ +5.50% | ▲ +6.52% | $1,754.00 (+3.24%) |
Oct 7, 2026 20d ago | 6-K | $1,545.00 $1,602.80 | ▲ +3.74% | ▲ +4.72% | $1,754.00 (+13.53%) |
Sep 28, 2026 29d ago | 6-K | $1,563.78 $1,551.38 | ▼ −0.79% | ▼ −2.00% | $1,754.00 (+12.16%) |
Jul 24, 2026 13w ago | 6-K | $1,690.80 $1,677.00 | ▼ −0.82% | ▼ −3.33% | $1,754.00 (+3.74%) |
Jun 22, 2026 18w ago | 6-K | $1,577.00 $1,646.22 | ▲ +4.39% | ▲ +4.84% | $1,754.00 (+11.22%) |
Jun 16, 2026 19w ago | 6-K | $1,628.00 $1,618.92 | ▼ −0.56% | ▲ +1.36% | $1,754.00 (+7.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers